Form 4 · Filed Jun 16, 2026, 08:03 PM UTC
IMVT/Immunovant, Inc.
Pande Atul — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | M | other | 1,500 | $8 | $12,645 | 118,231 |
| Jun 15, 2026 | S | sell | 1,500 | $34 | $51,030 | 116,731 |
| Jun 15, 2026 | M | other | 1,500 | — | — | 69,681 |
Source: SEC EDGAR raw filing ↗ · Accession 0001764013-26-000069